Even though we cannot replicate the TULIP finding on the high-risk potential of an insulin-resistant NAFLD, our current analysis of OptiFiT supports the findings of DPP and DREAM, highlighting that the response to interventions mainly depends on the glycemic state itself. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.